ERIN SIMPSON: Open Payments
NPI 1700299419 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 54 payments from 19 companies in 2025. Trend: 2023 $1,039 · 2024 $1,075 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $177 |
| Axsome Therapeutics, Inc. | 7 | $167 |
| Novo Nordisk Inc | 6 | $116 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| Lilly USA, LLC | 5 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| PFIZER INC. | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Antares Pharma, Inc. | 1 | $25 |
Products named: Auvelity, VRAYLAR, TRELEGY ELLIPTA, Wegovy, Kerendia, JARDIANCE, PREVNAR 20, XIFAXAN.
Industry payments across GA — which companies pay providers there.
